Author

Giuseppe Curigliano

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Electronic patient-reported outcomes platforms to shift from episodic to continuous oncology in breast cancer.

PURPOSE OF REVIEW To critically examine the clinical value of patient-reported outcomes (PROs) assessed through electronic tools (ePROs) in breast cancer, with a focus on their impact on patient management and real-world implementation. RECENT FINDINGS Accumulating evidence indicates that ePRO-based symptom monitorin...

Thanate Dajsakdipon, Luca Formenti, E. Ferraro et al. · Current Opinion in Oncology · 0 citations

Review Open access Sep 2026

Safety of combining radiation therapy and antibody-drug conjugates in patients with breast cancer: a systematic review and meta-analysis.

BACKGROUND AND PURPOSE The treatment landscape for breast cancer has undergone significant advancements in the recent years, with the introduction of several new anticancer agents, especially those belonging to the antibody-drug conjugates (ADCs) class. However, there exists a lack of comprehensive evidence regarding t...

L. Visani, C. Becherini, M. Kubeczko et al. · Radiotherapy and Oncology · 0 citations

Review Sep 2026

Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2-mutated and PALB2-mutated breast cancers.

PURPOSE OF REVIEW Germline or somatic biallelic inactivation of BRCA1, BRCA2 and PALB2 genes define a clinically and biologically distinct subset of breast cancers characterized by homologous recombination deficiency (HRD) and sensitivity to PARP inhibitors. Despite regulatory approvals of olaparib and talazoparib for...

J. Etessami, L. Tori, M. Aconito et al. · Current Opinion in Oncology · 0 citations